The developmental gene Chordin is amplified and expressed in human cancers.
Eric A SosaEdward M De RobertisPublished in: Molecular & cellular oncology (2023)
Chordin (CHRD) is a secreted protein important in early development, yet a role for CHRD in human disease has not been identified. In this study we investigated CHRD in cancer and normal adult tissues using the wealth of genome-wide data available in public databases. We found that Chordin is amplified in the DNA of specific cancers such as lung squamous cell and others, although copy number variation did not strictly correlate with higher mRNA expression. In some cancers, such as renal and stomach carcinomas, increased CHRD expression significantly correlated with poor survival. In normal adult human tissues, CHRD mRNA was highest in hepatocytes. Crossveinless-2/BMPER, a component of the Chordin morphogenetic pathway expressed at the opposite side in embryos, was expressed in liver stellate cells. This raises the intriguing possibility that a BMP gradient might be established in the extracellular matrix of the space of Disse that surrounds portal sinusoid capillaries.
Keyphrases
- copy number
- genome wide
- endothelial cells
- squamous cell
- extracellular matrix
- mitochondrial dna
- induced pluripotent stem cells
- childhood cancer
- dna methylation
- gene expression
- pluripotent stem cells
- binding protein
- poor prognosis
- big data
- induced apoptosis
- young adults
- emergency department
- bone marrow
- cell proliferation
- electronic health record
- lymph node metastasis
- high grade
- signaling pathway
- cell cycle arrest
- protein protein